脑膜瘤治疗策略的发展:从传统方法到新兴疗法

相关实验视频

Updated: Sep 11, 2025

Role of Diffusion MRI Tractography in Endoscopic Endonasal Skull Base Surgery

Role of Diffusion MRI Tractography in Endoscopic Endonasal Skull Base Surgery

Published on: July 5, 2021

Tirath Patel¹, Fathimathul Henna², Hamza Yousuf Ibrahim³

¹Trinity Medical Sciences University School of Medicine, Saint Vincent and Grenadines.

Annals of medicine and surgery (2012)

|August 11, 2025

概括

脑膜瘤治疗正在通过向疗法和针对侵袭性瘤的免疫疗法取得进展. 进一步的研究和临床试验对于改善挑战性脑膜瘤病例的结果至关重要.

科学领域:

神经瘤学神经瘤学
中枢神经系统新生体新生体
神经外科神经外科

背景情况:

脑膜瘤是常见的中枢神经系统瘤,较高的瘤表现出侵略性行为和耐治疗性.
大多数脑膜瘤是世卫组织I级 (良性),但非典型 (II级) 和形 (III级) 亚型存在重大临床挑战.

研究的目的:

审查脑膜瘤治疗策略的演变.
突出新兴疗法和持续挑战,特别是对于复发性和高度脑膜瘤.

主要方法:

对2000年至2025年间发表的研究进行了叙述性审查.
搜索的数据库包括PubMed,Scopus和谷歌学者,使用关键词如"脑膜瘤"",手术"",放射治疗"",向治疗"和"免疫治疗".

主要成果:

手术切除仍然是主要的治疗方法,切除的程度对复发率至关重要.
放射治疗 (分断和立体疗法) 对不完整的切除或不可切除的瘤至关重要.
分子分析揭示了NF2,TRAF7和激素受体等点;新兴的治疗方法包括mTOR抑制剂,抗血管原剂,免疫疗法 (PD-1/PD-L1抑制剂) 和受体放射性核酸治疗 (PRRT).

结论:

侵袭性脑膜瘤管理正在向分子和免疫治疗方法发展.
整合手术,辐射和向治疗的多学科战略至关重要.
需要加强临床试验和生物标志物研究,以改善挑战性脑膜瘤患者的治疗结果.

关键词:

免疫疗法免疫疗法脑膜瘤是指脑膜的部分.分子疗法的分子疗法.手术切除手术切除是指手术切除.

更多相关视频

Glioblastoma Relapse Post-Resection Model for Therapeutic Hydrogel Investigations

Glioblastoma Relapse Post-Resection Model for Therapeutic Hydrogel Investigations

Published on: February 24, 2023

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.